biotech / news / / Benzinga
Roche says it will acquire U.S.-based digital pathology and AI company PathAI in a deal worth up to $1.05 billion.
Roche will acquire PathAI for up to $1.05 billion, including $750 million upfront.
KEY POINTS
- PathAI's Image Management System, AISight, will be integrated into Roche's oncology diagnostics platforms.
- PathAI's AI tools will expand Roche's capabilities in clinical trials and translational research support.
- The acquisition builds on a Roche-PathAI partnership first established in 2021 and expanded in 2024.
- Combined technologies are expected to accelerate biomarker discovery and personalized healthcare diagnostics.
COMPANIES
Summarized by Newsio from Benzinga. How we summarize →